U.S. Markets closed

Amgen shares fall after lung cancer drug misses forecasts

Yahoo Finance's Dan Roberts, Sibile Marcellus, and Julia La Roche discuss Amgen's falling stock after it's key lung cancer drug missed Wall Street forecasts.